Powell Andrew Kenneth William has filed 4 insider transactions across 1 company since March 2024.
Most recent transaction: a option exercise of 4660 shares of Aclaris Therapeutics, Inc. ($ACRS) on June 01, 2024.
Activity breakdown: 2 open-market purchases and 0 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| June 1, 2024 | Aclaris Therapeutics, Inc. | $ACRS | Powell Andrew Kenneth William | Not found | M | Common Stock | 4660 | $0.00 | 33,523.0000 | 71,074,858 | 16.15% | 0.01% |
| June 1, 2024 | Aclaris Therapeutics, Inc. | $ACRS | Powell Andrew Kenneth William | Not found | M | Restricted Stock Units | 4660 | $0.00 | 0.0000 | 71,074,858 | 100.00% | 0.01% |
| March 1, 2024 | Aclaris Therapeutics, Inc. | $ACRS | Powell Andrew Kenneth William | Director | P | Common Stock | 8500 | $1.23 | 22,863.0000 | 69,808,855 | 59.18% | 0.01% |
| March 4, 2024 | Aclaris Therapeutics, Inc. | $ACRS | Powell Andrew Kenneth William | Director | P | Common Stock | 6000 | $1.25 | 28,863.0000 | 69,808,855 | 26.24% | 0.01% |